MetaADEDB 2.0 @ LMMD
Fenfluramine
(DBGIVFWFUFKIQN-UHFFFAOYSA-N)
Structure
SMILES
CCNC(Cc1cccc(c1)C(F)(F)F)C
Type(s)
Approved; Illicit; Investigational; Withdrawn
ATC code(s)
A08AA02
Molecular Formula:
C12H16F3N
Molecular Weight:
231.257
Log P:
3.6368
Hydrogen Bond Acceptor:
1
Hydrogen Bond Donor:
1
TPSA:
12.03
CAS Number(s):
458-24-2; 16105-77-4
Synonym(s)
1.
Fenfluramine
2.
Fenfluramine Hydrochloride
3.
Fenfluramine Hydrochloride, (+-)-Isomer
4.
Fenfluramine Hydrochloride, R-Isomer
5.
Fenfluramine, (+-)-Isomer
6.
Fenfluramine, R-Isomer
7.
Isomeride
8.
Pondimin
9.
Fenfluramine Hydrochloride, R Isomer
10.
Fenfluramine, R Isomer
11.
Hydrochloride, Fenfluramine
External Link(s)
MeSHD005277
PubChem Compound3337
BindingDB84738
ChEBI5000
CHEMBLCHEMBL87493
DrugBankDB00574
DrugCentral1150
IUPHAR/BPS Guide to PHARMACOLOGY4613
KEGGcpd:C06996
dr:D07945
Therapeutic Target DatabaseD09WNK
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Abdominal PainCanada Vigilance: 2Canada Vigilance
2Anemia, Hemolytic4706826CTD
3Anorexia4118627CTD
4Anxiety Disorders8545621CTD
5Aortic Valve Insufficiency

View details

CTD
6Autistic Disorder2606882
3709993
6502317
CTD
7Bipolar Disorder9714271CTD
8Bradycardia9477076CTD
9Bruxism4326288CTD
10Cardiomyopathies4055256CTD
11Catalepsy2972934
8386235
CTD
12Catatonia8887967CTD
13Cerebral Hemorrhage9270617CTD
14Chemical and Drug Induced Liver Injury10469626CTD
15Cocaine-Related Disorders9598218
9668665
17071819
CTD
16Confusion5354861CTD
17Depressive disorder

View details

CTD
18Diarrhea4895336CTD
19Dizziness6753613CTD
20Dyskinesia, Drug-Induced4847362
5354861
6493634
CTD
21Endomyocardial Fibrosis9565497CTD
22Fatigue6753613CTD
23Feeding and Eating Disorders8223940CTD
24Fever2889795
4048012
CTD
25Growth Disorders10469626CTD
26Hallucinations4414229CTD
27HeadacheCanada Vigilance: 15354861CTD
Canada Vigilance
28Heart Diseases848709
9818470
CTD
29Heart failure2376256
11581595
CTD
30Hyperprolactinemia1678730CTD
31Hypotension9477076CTD
32Hypoxia2367283CTD
33Insulin Resistance10574509CTD
34Lethargy4895336CTD
35Mitral Valve Insufficiency

View details

CTD
36Mood Disorders3709993CTD
37Movement Disorders16817869CTD
38Nausea5354861CTD
39Obesity

View details

CTD
40Pain8446441CTD
41Panic Disorder9361714CTD
42Personality Disorders7197574CTD
43Precancerous Conditions10469626CTD
44Psychoses, Substance-Induced4414229
5354861
5440606
CTD
45Pulmonary Edema8681646CTD
46Pulmonary Valve Insufficiency

View details

CTD
47Schizophrenia4414229CTD
48Seizures1116545CTD
49Sleep Initiation and Maintenance Disorders3308829CTD
50Sleep Wake Disorders4326288CTD
51Status Epilepticus7667346CTD
52Substance Withdrawal Syndrome5073787
5460561
CTD
53TachycardiaCanada Vigilance: 1Canada Vigilance
54Tricuspid Valve Insufficiency

View details

CTD
55Vascular Diseases10383810CTD
56Xerostomia6753613CTD
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.